Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Zydus Lifesciences ropes in Tushar Shroff as President-Finance

Ruchika Sharma1 May 2025 2:30 PM IST

Gujarat: Zydus Lifesciences has announced the appointment of Tushar Shroff as a President-Finance."This is to inform that based on the...

JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterations

JnJ Imaavy gets USFDA okay for generalized myasthenia gravis

Ruchika Sharma1 May 2025 1:15 PM IST

Spring House: Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for IMAAVY (nipocalimab-aahu), a human...

CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III Trial

Novartis to acquire kidney disease drug maker Regulus Therapeutics for up to 1.7 billion

Ruchika Sharma1 May 2025 12:30 PM IST

Transaction includes USD 0.8 billion upfront with a potential additional USD 0.9 billion payment upon the achievement of a future regulatory...

Strides Pharma Science Singapore arm secures USFDA nod for nonsteroidal anti-inflammatory drug

Ruchika Sharma1 May 2025 11:35 AM IST

Bangalore: Strides Pharma Global Pte. Limited, a step-down wholly owned subsidiary of Strides Pharma Science Limited in Singapore, has received...

Gland Pharma bags USFDA nod for glaucoma drug

Ruchika Sharma30 April 2025 4:40 PM IST

Hyderabad: Gland Pharma Limited, a generic injectable & ophthalmic focused pharmaceutical company, has announced that the company has...

USFDA approves AbbVie giant cell arteritis drug Rinvoq in adults

Ruchika Sharma30 April 2025 4:30 PM IST

North Chicago, Ill.: AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib), 15 mg, once daily,...

Manipal Health Clinches Sahyadri Deal For Rs 6,400 Cr After Intense Bidding War: Report

Strides Pharma buys four approved ANDAs from Nostrum Labs for over Rs 17 crore

Ruchika Sharma30 April 2025 3:28 PM IST

Bengaluru: Strides Pharma Inc., a Step-down wholly-owned subsidiary of Strides Pharma Science Limited in the US, has acquired four...

USFDA extends review period for Bayer Elinzanetant

USFDA issues EIR for Alembic Pharma Panelav facility

Ruchika Sharma30 April 2025 2:46 PM IST

Vadodara: Alembic Pharma, an Indian multinational pharmaceutical company, has announced that the Company has received an Establishment...

CDSCO Panel Clears AstraZenecas Datopotamab for Breast Cancer, Seeks Phase IV Trial

Fixed duration Calquence based regimens recommended for EMA Committee for chronic lymphocytic leukaemia: AstraZenaca

Ruchika Sharma30 April 2025 1:30 PM IST

AstraZeneca has announced that a fixed-duration regimen of Calquence (acalabrutinib) in combination with venetoclax, with or without...

AstraZeneca discontinues Phase 3 trial of Truqap in metastatic castration-resistant prostate cancer

Ruchika Sharma30 April 2025 12:14 PM IST

Truqap was discovered by AstraZeneca subsequent to a collaboration with Astex Therapeutics.

India Cuts API Imports, Disburses Rs 1,008 Cr Under PLI Schemes, Parliament Told

Zydus Lifesciences wins USFDA okay for cholesterol-lowering drug Niacin Extended Release

Ruchika Sharma30 April 2025 11:15 AM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food and Drug...

CDSCO panel grants clearance to Morepen Labs to conduct BE studies for fatty liver disease drug Resmetirom

Ruchika Sharma29 April 2025 4:11 PM IST

Gurugram: Morepen Laboratories Ltd. has received clearance from the Subject Expert Committee (SEC) of Central Drugs Standard Control...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok